Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc (INDV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INDV · as of Jun 8, 2026
Key Statistics
Explore Indivior Pharmaceuticals Inc Data
indv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The INDV analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $49.00, representing +30.27% upside from the current price of $37.62.
Competitors & Peers
indv competitorsINDV
ACAD
ADMA
AMRX
CRNX
HNGEStock Performance
Full HistoryAbout Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products inc…
what is indivior pharmaceuticals inc · indv stock overview · indivior pharmaceuticals inc company profile · who is indivior pharmaceuticals inc ceo · indv NASDAQ · indivior pharmaceuticals inc headquarters · indivior pharmaceuticals inc business segments
About Stock Overview & Key Data
Indivior Pharmaceuticals Inc (INDV) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Dec 29, 2014. As of the latest trading session, INDV stock price is $37.62, with a market capitalization of $4.7B. The stock has returned +180.08% over the past 12 months and +4.84% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Indivior Pharmaceuticals Inc stock is Buy, with an average 12-month price target of $49.00. In fiscal year 2025, Indivior Pharmaceuticals Inc reported revenue of $1.2B and net income of $210.0M. For detailed data — including Indivior Pharmaceuticals Inc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Indivior Pharmaceuticals Inc (INDV) stock price is $37.62. The stock is traded on NASDAQ under the ticker symbol INDV. The 52-week range is $13.42 – $41.00.